Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《The Chinese Journal of Clinical Pharmacology》 2017-16
Add to Favorite Get Latest Update

Research status of tolvaptan in the treatment of acute decompensated heart failure

WANG Yang;LIU Gui-hua;Department of Emergency, Peking University Third Hospital;  
Acute decompensated heart failure is one of the leading causes of hospitalization worldwide and is associated with a poor prognosis.Tolvaptan shows the evidences of relieving the symptoms of congestion in acute decompensated heart failure patients and does not cause worsening renal function and hyponatremia. This article summarizes research status of tolvaptan in the treatment of acute decompensated heart failure.
【CateGory Index】: R541.6
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved